Author details

Full Name

Yasin Senbabaoglu

Affiliation

ORCID

Career Start Year

2010

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36599350	CD8<sup>+</sup> TÂ cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy.	Cell Rep Med	2023
37741832	Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer.	Nat Commun	2023
34879110	The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology.	PLoS One	2021
33588426	CTLA-4 blockade drives loss of T stability in glycolysis-low tumours.	Nature	2021
33903764	Gremlin 1<sup>+</sup> fibroblastic niche maintains dendritic cell homeostasis in lymphoid tissues.	Nat Immunol	2021
34260887	Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1.	Immunity	2021
34085925	Multiplexed proteomics of autophagy-deficient murine macrophages reveals enhanced antimicrobial immunity via the oxidative stress response.	Elife	2021
32589946	The Immunoglobulin Superfamily Receptome Defines Cancer-Relevant Networks Associated with Clinical Outcome.	Cell	2020
31699795	Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15 Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy.	Cancer Discovery	2020
31237614	Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases.	J Clin Endocrinol Metab	2019
29358708	Selective autophagy of the adaptor TRIF regulates innate inflammatory signaling.	Nat Immunol	2018
30300585	Non-conventional Inhibitory CD4<sup>+</sup>Foxp3<sup>-</sup>PD-1<sup>hi</sup> T Cells as a Biomarker of Immune Checkpoint Blockade Activity.	Cancer Cell	2018
29894689	Non-conventional Inhibitory CD4<sup>+</sup>Foxp3<sup>-</sup>PD-1<sup>hi</sup> T Cells as a Biomarker of Immune Checkpoint Blockade Activity.	Cancer Cell	2018
29443960	TGFÎ² attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	Nature	2018
28249590	Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.	Genome Biol	2017
29132146	Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.	Nature	2017
27777979	The head and neck cancer immune landscape and its immunotherapeutic implications.	JCI Insight	2016
26840267	Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.	Oncotarget	2016
26928298	A Multi-Method Approach for Proteomic Network Inference in 11 Human Cancers.	PLoS Comput Biol	2016
26947078	Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.	Cell Rep	2016
26901439	Mitochondrial DNA copy number variation across human cancers.	Elife	2016
27855702	Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.	Genome Biol	2016
26061751	Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.	N Engl J Med	2015
25673823	Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity.	Molecular Cancer Therapeutics	2015
26169480	Graph Curvature for Differentiating Cancer Networks.	Scientific Reports	2015
25158761	Critical limitations of consensus clustering in class discovery.	Scientific Reports	2014
23574736	OKVAR-Boost: a novel boosting algorithm to infer nonlinear dynamics and interactions in gene regulatory networks.		2013
24071851	Emerging landscape of oncogenic signatures across human cancers.	Nat Genet	2013
22912392	Genomic estimates of aneuploid content in glioblastoma multiforme and improved classification.	Clinical Cancer Research	2012
19933593	Joint estimation of DNA copy number from multiple platforms.		2010